Provided by Tiger Trade Technology Pte. Ltd.

Allstate

257.80
-1.7000-0.66%
Post-market: 257.800.00000.00%19:45 EDT
Volume:2.18M
Turnover:563.59M
Market Cap:65.19B
PE:5.16
High:261.47
Open:260.12
Low:257.76
Close:259.50
52wk High:277.22
52wk Low:188.08
Shares:252.86M
Float Shares:248.44M
Volume Ratio:1.79
T/O Rate:0.88%
Dividend:4.16
Dividend Rate:1.61%
EPS(TTM):49.94
EPS(LYR):38.06
ROE:46.11%
ROA:8.68%
PB:2.06
PE(LYR):6.77

Loading ...

Allstate estimates May catastrophe losses at $289 million

Reuters
·
Jun 18

Allstate (ALL) Stock Could Be 7.8% Undervalued After Keefe Bruyette Downgrade

Simply Wall St.
·
Jun 17

Macquarie Remains a Hold on Atlantic Lithium (ALL)

TIPRANKS
·
Jun 16

Aristocrat Leisure (ASX:ALL) Is Up 5.1% After Expanding A$2.5b Buyback And Posting Strong H1 Results

Simply Wall St.
·
Jun 15

Aristocrat Leisure (ASX:ALL) Shares Valuation Check After A$2.5b Buy-Back Extension And Earnings Update

Simply Wall St.
·
Jun 13

3 U.S. Large Cap Value Stocks Quietly Leveraged To Inflation

Simply Wall St.
·
Jun 12

Allstate Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 12

Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026

GlobeNewswire
·
Jun 11

Movement Alert|Allstate Rises 3.26% in Regular Trading, Trading at $224.735

Market Focus
·
Jun 11

Cellectis Gains FDA RMAT Status for Allogeneic CAR-T lasme-cel in r/r B-ALL

TIPRANKS
·
Jun 10

Allstate Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 10

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

GlobeNewswire
·
Jun 10

A Look At Allstate (ALL) Valuation After Recent Share Price Pullback And Modest Undervaluation Estimate

Simply Wall St.
·
Jun 10

Allstate Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 09

Property Insurers Are Piling Into Private Assets, as Other Investors Hit Pause -- WSJ

Dow Jones
·
Jun 09

Allstate Shares Fall After Keefe Bruyette & Woods Downgrade

MT Newswires Live
·
Jun 09

Allstate Cut to Market Perform From Outperform by Keefe, Bruyette & Woods

Dow Jones
·
Jun 09

Press Release: Vaxart Urges Shareholders to Vote "FOR" ALL Six of the Company's Highly Qualified Director Nominees on the WHITE Proxy Card TODAY

Dow Jones
·
Jun 08

Keefe Bruyette & Woods Downgrades Allstate to Market Perform From Outperform, Adjusts PT to $242 From $266

MT Newswires Live
·
Jun 08

U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex

Reuters
·
Jun 08